Beam Therapeutics Inc

NASDAQ:BEAM  
68.05
-4.51 (-6.22%)
4:35:44 PM EDT: $69.80 +1.75 (+2.57%)
Earnings Announcements

Beam Therapeutics Provides Business And Pipeline Updates And Reports Third Quarter 2021 Financial Results

Published: 11/08/2021 11:21 GMT
Beam Therapeutics Inc (BEAM) - Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.42.
Q3 Earnings per Share View $-0.74 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.56 Million
Adjusted EPS is expected to be -$0.97

Next Quarter Revenue Guidance is expected to be $1.7 Million
Next Quarter EPS Guidance is expected to be -$1.04

More details on our Analysts Page.